AlaRS Antibodies

Santa Cruz Biotechnology features a diverse variety of AlaRS monoclonal antibodies for investigating alanine-tRNA synthetase in research applications. AlaRS Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Alanine-tRNA synthetase is essential for protein synthesis, catalyzing the attachment of alanine to its corresponding tRNA, ensuring accurate translation of genetic information into functional proteins. The enzyme maintains a significant role in cellular metabolism and is involved in various physiological processes, making it a key target for research in fields such as cancer biology and neurobiology. Understanding alanine-tRNA synthetase function can provide valuable insights into cellular processes and potential therapeutic approaches. Investigating the relationship between alanine-tRNA synthetase and disease progression helps researchers develop new treatment strategies. AlaRS monoclonal antibodies enable precise detection and analysis of alanine-tRNA synthetase expression patterns across different tissues and experimental conditions. Santa Cruz Biotechnology monoclonal antibodies for AlaRS support researchers worldwide in advancing scientific understanding of protein synthesis and cellular regulation.